Patients with Crohn’s disease achieving transmural healing experience superior long-term outcomes compared with those with endoscopic or radiologic healing alone
Open Access
- 3 July 2026
- journal article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 32 (11) , 2160-2168
Abstract
Background: Crohn’s disease (CD) is characterized by transmural inflammation, and achieving transmural healing (TH), may lead to improved long-term outcomes. However, evidence supporting this hypothesis is limited. Methods: Adult patients diagnosed with CD who underwent ileocolonoscopy and cross-sectional imaging within 6 months were included. Long-term outcomes of CD-related surgery and hospitalization in patients with TH, endoscopic healing (EH) alone, radiologic healing (RH) alone, and no healing (NH) were assessed. We used Cox proportional hazards models and modified Poisson regression. Results: Among 180 included patients, 26.7% achieved TH, 21.1% achieved EH, 12.8% achieved RH, and 39.4% were classified as NH. At baseline, 54.4% were on biologics which increased to 81.7% at last follow-up (76-78 months across groups). Cumulative probabilities of surgery were lowest in patients with TH (0%, 2.3%, 7.0% at 1, 3, and 5 years) and highest in patients with NH (13%, 20.5%, and 26.9%, respectively) (P = .03). On Cox proportional hazard regression analysis, TH was associated with a significantly reduced risk of CD-related surgery (hazard ratio, 0.01; 95% confidence interval, 0.00-0.35; P = .009) compared with NH. The probabilities of surgery were lower for patients with RH compared with EH (10% vs 13.2%, 10% vs 18.4%, and 21.2% vs 26.9% at 1, 3, and 5 years) but were not statistically significant (P = .41). Probabilities of CD-related hospitalization were lowest with TH (4.3%, 8.8%, and 13.6% at 1, 3 and 5 years) but were not statistically different than other healing categories (P = .67). Conclusions: TH was associated with superior long-term outcomes compared with EH or RH alone. Future studies should focus on standardizing its definition and evaluate treat-to-target strategies.Keywords
This publication has 24 references indexed in Scilit:
- International Magnetic Resonance Imaging Consensus for Use in Luminal Crohn’s Disease Trials and Clinical PracticeClinical Gastroenterology and Hepatology, 2025
- Is transmural healing better than mucosal healing in pediatric Crohn’s disease?Digestive and Liver Disease, 2025
- Early Biological Therapy Within 12 Months of Diagnosis Leads to Higher Transmural Healing Rates in Crohn’s DiseaseClinical Gastroenterology and Hepatology, 2024
- Development and Validation of a Score to Assess Transmural Healing and Response in Patients With Crohn’s DiseaseClinical Gastroenterology and Hepatology, 2024
- Transmural remission improves clinical outcomes up to 5 years in Crohn's diseaseUnited European Gastroenterology Journal, 2022
- Ultrasonography Tight Control and Monitoring in Crohn’s Disease During Different Biological Therapies: A Multicenter StudyClinical Gastroenterology and Hepatology, 2022
- Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trialThe Lancet Gastroenterology & Hepatology, 2018
- Crohn's diseaseThe Lancet, 2012
- Endoscopic Skipping of the Distal Terminal Ileum in Crohn's Disease Can Lead to Negative Results From IleocolonoscopyClinical Gastroenterology and Hepatology, 2012
- Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammationInflammatory Bowel Diseases, 2012